(Q28293763)

English

Copolymer 1 reduces relapse rate and improves disability in relapsing-remitting multiple sclerosis: results of a phase III multicenter, double-blind placebo-controlled trial. The Copolymer 1 Multiple Sclerosis Study Group

scientific article

In more languages
default for all languages
No label defined

No description defined

Statements

Copolymer 1 reduces relapse rate and improves disability in relapsing-remitting multiple sclerosis: results of a phase III multicenter, double-blind placebo-controlled trial. The Copolymer 1 Multiple Sclerosis Study Group (English)
0 references
K P Johnson
0 references
B R Brooks
0 references
J A Cohen
0 references
C C Ford
0 references
J Goldstein
0 references
R P Lisak
0 references
L W Myers
0 references
H S Panitch
0 references
J W Rose
0 references
R B Schiffer
0 references
July 1995
0 references
0 references
45
0 references
7
0 references
1268-76
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit